Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1990 | 12-1989 | 12-1988 | |
| Sales | 3,836 | 534 | 0 |
| Cost of Goods | 0 | 3,136 | 0 |
| Gross Profit | -2,450 | -2,603 | 0 |
| Operating Expenses | 2,018 | 1,196 | 1,003 |
| Operating Income | 1,819 | -3,662 | -1,003 |
| Interest Expense | 10 | 23 | 7 |
| Other Income | -5,107 | 1,029 | 55 |
| Pre-tax Income | -3,298 | -2,656 | -954 |
| Net Income Continuous | -3,298 | -2,656 | -954 |
| Net Income | $-3,298 | $-2,656 | $-954 |
| EPS Basic Total Ops | -0.63 | -0.55 | N/A |
| EPS Basic Continuous Ops | -0.63 | -0.55 | N/A |
| EPS Diluted Total Ops | -0.63 | -0.55 | N/A |
| EPS Diluted Continuous Ops | -0.63 | -0.55 | N/A |
| EBITDA(a) | $2,143 | $-3,469 | $-989 |